Send to a Friend Share

Sangamo Biosciences (SGMO) Files $100M Mixed Shelf

February 23, 2012 7:18 AM EST
SGMO Hot Sheet
Overall Analyst Rating:
    SELL (= Flat)

Revenue Growth %: +45.5%
Sangamo Biosciences, Inc. (Nasdaq: SGMO), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

Equity Offerings

Add Your Comment





Follow StreetInsider.com On Twitter